share_log

中国网络信息科技(08055):深圳市九九拍将协助泰诺(深圳)建立线上销售平台泰诺商城

China Network Information Technology (08055): Shenzhen Jiujiubai will assist Tylenol (Shenzhen) to establish an online sales platform Tylenol Mall.

智通財經 ·  Dec 1, 2021 04:35

Zitong Financial App News, China Network Information Technology (08055) announced that on November 30, 2021, the company's wholly-owned subsidiary Tylenol (Shenzhen) Technology Consulting Co., Ltd. (Tylenol (Shenzhen)) (a company established in China on November 18, 2021) and Shenzhen Jiujiupai Network Technology Co., Ltd. (Shenzhen Jiujiupai) entered into a non-legally binding letter of intent for the business cooperation between the two sides. The main business scope of Tylenol (Shenzhen) is software development, software sales, electronic products and daily necessities sales and so on.

It is reported that Shenzhen Jiujiupai is a company established in China, which mainly operates Jiujiupai, an online shopping platform developed independently by its members. Members of the platform who have taken pictures for a long time can get points and rewards after spending on the platform for a long time.

According to the letter of intent, Shenzhen Jiujiubai will assist Tylenol (Shenzhen) to establish its online sales platform (Tylenol Mall), while Tylenol Mall will operate on the Jiujiupai platform. The Tylenol Mall, which will be set up on the Jiujiu shooting platform, will be the online product sales platform, and registered members will be rewarded with points after spending in the Tylenol Mall. Under the current business cooperation intention, members of Tylenol Mall and Jiujioupai platform can exchange points for products on Tylenol Mall and Jiujiupai platform (that is, Tylenol Mall members can use the points earned in Tylenol Mall to exchange the products sold on Jiujiupai platform, and vice versa).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment